XML 64 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Statement [Abstract]      
NET SALES $ 27,083us-gaap_SalesRevenueNet $ 27,544us-gaap_SalesRevenueNet $ 31,480us-gaap_SalesRevenueNet
COST OF GOODS SOLD 17,362us-gaap_CostOfGoodsAndServicesSold 16,790us-gaap_CostOfGoodsAndServicesSold 18,348us-gaap_CostOfGoodsAndServicesSold
Gross profit 9,721us-gaap_GrossProfit 10,754us-gaap_GrossProfit 13,132us-gaap_GrossProfit
OPERATING EXPENSES:      
Selling, general and administrative 24,146us-gaap_SellingGeneralAndAdministrativeExpense 23,301us-gaap_SellingGeneralAndAdministrativeExpense 20,145us-gaap_SellingGeneralAndAdministrativeExpense
Research and development 2,897us-gaap_ResearchAndDevelopmentExpense 3,212us-gaap_ResearchAndDevelopmentExpense 2,491us-gaap_ResearchAndDevelopmentExpense
Operating Expenses 27,043us-gaap_OperatingExpenses 26,513us-gaap_OperatingExpenses 22,636us-gaap_OperatingExpenses
LOSS FROM OPERATIONS (17,322)us-gaap_OperatingIncomeLoss (15,759)us-gaap_OperatingIncomeLoss (9,504)us-gaap_OperatingIncomeLoss
OTHER INCOME (EXPENSE):      
Interest expense, net (665)tbio_InterestIncomeAndExpenseNet (642)tbio_InterestIncomeAndExpenseNet (888)tbio_InterestIncomeAndExpenseNet
Warrant revaluation 455tbio_StockWarrantsRevaluation 300tbio_StockWarrantsRevaluation 2,200tbio_StockWarrantsRevaluation
Gain on sale of product line 4,114us-gaap_GainLossOnSaleOfBusiness 0us-gaap_GainLossOnSaleOfBusiness 0us-gaap_GainLossOnSaleOfBusiness
Other, net 0us-gaap_OtherNonoperatingIncomeExpense 60us-gaap_OtherNonoperatingIncomeExpense 11us-gaap_OtherNonoperatingIncomeExpense
Other Income (Expense) 3,904tbio_OtherIncomeExpense (282)tbio_OtherIncomeExpense 1,323tbio_OtherIncomeExpense
LOSS BEFORE INCOME TAXES (13,418)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (16,041)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (8,181)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
INCOME TAX EXPENSE (BENEFIT) 524us-gaap_IncomeTaxExpenseBenefit (54)us-gaap_IncomeTaxExpenseBenefit 146us-gaap_IncomeTaxExpenseBenefit
NET LOSS (13,942)us-gaap_NetIncomeLoss (15,987)us-gaap_NetIncomeLoss (8,327)us-gaap_NetIncomeLoss
PREFERRED STOCK DIVIDENDS AND ACCRETION (1,144)us-gaap_PreferredStockDividendsAndOtherAdjustments (726)us-gaap_PreferredStockDividendsAndOtherAdjustments (660)us-gaap_PreferredStockDividendsAndOtherAdjustments
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (15,086)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (16,713)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (8,987)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
BASIC AND DILUTED LOSS PER COMMON SHARE (IN USD PER SHARE) $ (2.01)us-gaap_EarningsPerShareBasicAndDiluted [1] $ (2.30)us-gaap_EarningsPerShareBasicAndDiluted [1] $ (1.55)us-gaap_EarningsPerShareBasicAndDiluted [1]
BASIC AND DILUTED WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING 7,493,844us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted [1] 7,266,642us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted [1] 5,794,785us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted [1]
[1] Net loss per share and the number of shares used in the per share calculations for all periods presented reflect the one-for-twelve reverse stock split which took effect on January 27, 2014.